Trade Names/Brand Names :
- Tudorza Pressair.
Why it is prescribed :
This medication is an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. It relaxes airway muscles that result in easy breathing. It relaxes airway muscles that results in easy breathing.
When it is not to be taken (Contraindications):
Category C :
Animal studies have shown adverse effects on the fetus and there are no appropriate studies in pregnant women, but potential benefits may allow the use of the drug in pregnant women despite the potential for risks.
Dosage & When it is to be taken (Indications):
Inhalation- One oral inhalation of 400 mcg twice daily.
How it should be taken :
It comes as a powder for inhalation, use as directed by your physician.
Warnings and Precautions :
• Not for acute use: Not for use as a rescue medication.
Caution should be exercised in patients with history of narrow-angle glaucoma, urinary retention, any allergy, who are taking other medications, liver or kidney impairment, elderly, children, during pregnancy and breastfeeding.
It is not intended for the initial treatment of acute episodes of bronchospasm.
Avoid contact with eyes; otherwise it may cause blurred vision.
Side Effects :
• Most Common
Headache, common cold and cough.
Nose inflammation, diarrhea, sinus inflammation, toothache, vomiting.
Other Precautions :
Avoid excess dosage.
Once opened, the inhaler should be discarded after 45 days.
Aclidinium use should be discontinued in patients who have severe bronchospasm after treatment with the drug.
Storage Conditions :
Store it in room temperate (25°C).